References
<A NAME="RG26903ST-1A">1a</A>
Ho T.-L.
Enantioselective Synthesis: Natural Products from Chiral Terpenes
John Wiley and Sons;
New York:
1992.
<A NAME="RG26903ST-1B">1b</A>
Seyden-Penne J.
Chiral Auxiliaries and Ligands in Asymmetric Synthesis
John Wiley and Sons;
New York:
1995.
<A NAME="RG26903ST-1C">1c</A>
Koskinen A.
Asymmetric Synthesis of Natural Products
John Wiley and Sons;
Chichester:
1998.
<A NAME="RG26903ST-1D">1d</A>
Oppolzer W.
Tetrahedron
1987,
43:
1969
<A NAME="RG26903ST-1E">1e</A>
Blaser H.-U.
Chem. Rev.
1992,
92:
935
<A NAME="RG26903ST-2">2</A> An interesting review on the preparation of camphor derivatives is:
Money T.
Nat. Prod. Rep.
1985,
253
A plethora of examples on the synthetic use of chiral agents 2 and 3 has been reported (some of them are described in ref. 1). About intermediate 1(H/CH = CH
2
) see:
<A NAME="RG26903ST-3A">3a</A>
Paquette LA.
Zhao M.
J. Am. Chem. Soc.
1998,
120:
5203
<A NAME="RG26903ST-3B">3b</A>
Paquette LA.
Wang H.-L.
Su Z.
Zhao M.
J. Am. Chem. Soc.
1998,
120:
5213
<A NAME="RG26903ST-3C">3c</A> About catalyst 4 and other related derivatives see:
García Martínez A.
Teso Vilar E.
García Fraile A.
de la Moya Cerero S.
Lora Maroto B.
Tetrahedron: Asymmetry
2003,
14:
1959 ; and references therein
<A NAME="RG26903ST-4A">4a</A>
Stevens RV.
Chang JH.
Lapalme R.
Schow S.
Schlageter MG.
Shapiro R.
Weller HN.
J. Am. Chem. Soc.
1983,
105:
7719
<A NAME="RG26903ST-4B">4b</A>
Stevens RV.
Lawrence DS.
Tetrahedron
1985,
41:
93
<A NAME="RG26903ST-4C">4c</A>
Stevens RV.
Beaulieu N.
Chang W.-H.
Daniewski AR.
Takeda T.
Waldner A.
Williard PG.
Zutter U.
J. Am. Chem. Soc.
1986,
108:
1039
<A NAME="RG26903ST-5A">5a</A>
Richou O.
Vaillancourt V.
Faulkner DJ.
Albizati KF.
J. Am. Chem. Soc.
1989,
54:
4729
<A NAME="RG26903ST-5B">5b</A>
Vaillancourt V.
Albizati KF.
J. Org. Chem.
1992,
57:
3627
<A NAME="RG26903ST-5C">5c</A>
Agharahimi RM.
LeBel NA.
J. Org. Chem.
1995,
60:
1856
<A NAME="RG26903ST-6A">6a</A>
Eck CR.
Mills RW.
Money T.
J. Chem. Soc., Perkin Trans. 1
1975,
251
<A NAME="RG26903ST-6B">6b</A>
Dadson WM.
Lam M.
Money T.
Piper SE.
Can. J. Chem.
1983,
61:
343
<A NAME="RG26903ST-7A">7a</A>
Komarov IV.
Gorichko MV.
Kornilov MY.
Tetrahedron: Asymmetry
1997,
8:
435
<A NAME="RG26903ST-7B">7b</A>
Komarov IV.
Monsees A.
Kadyrov R.
Fischer C.
Schmidt U.
Börner A.
Tetrahedron: Asymmetry
2002,
13:
1615
<A NAME="RG26903ST-7C">7c</A>
Komarov IV.
Monsees A.
Spannenberg A.
Baumann W.
Schmidt U.
Fischer C.
Börner A.
Eur. J. Org. Chem.
2003,
138
<A NAME="RG26903ST-8">8</A> For a review see:
de la Moya Cerero S.
García Martínez A.
Teso Vilar E.
García Fraile A.
Lora Maroto B.
J. Org. Chem.
2003,
68:
1451
<A NAME="RG26903ST-9">9</A>
Treatment of commercial enantiopure 3-endo-,9-dibromocamphor with Zn-HOAc (standard conditions, see ref.
[2]
) produces the selective removal of the C(3)-bromine, giving place to pure 1(Br/H) in 95% yield.
<A NAME="RG26903ST-10">10</A>
The reaction of 1(Br/H) with Tf2O was realized under the standard conditions described by us for other related 2-norbornanones
(ref.
[8]
). After chromatography (silica gel and hexane), pure triflate 5(Br) was obtained as a colorless liquid in 77% yield. [α]D
20 -55.5 (c 1.96, CH2Cl2). 1H NMR and 13C NMR, IR and MS agree with the structure.
<A NAME="RG26903ST-11">11</A>
Alcohol 6(Br) was obtained by standard treatment of 5(Br) with LAH (e.g. ref.
[8]
). Purification by chromatography (silica gel and CH2Cl2/Et2O 95:5) yields pure alcohol 6(Br) as a colorless solid in 78% yield. Mp 72-74 °C. [α]D
20 -57.3 (c 0.67, CH2Cl2). 1H NMR and 13C NMR, IR and MS agree with the structure.
<A NAME="RG26903ST-12">12</A>
A solution of 6(Br) and an excess of corresponding N-halosuccinimide (NYS) in CH2Cl2 was stirred at r.t. overnight. After standard work up and purification by chromatography
(silica gel and hexane/CH2Cl2 6: 4), corresponding pure 1(Br/Y) was obtained as a colorless solid. Compound 1(Br/Br): 85% yield. Characterization data agree with the previously described in ref.
[6b]
Compound 1(Br/Cl): 83 yield. Mp 64-66 °C. [α]D
20 +88.6 (c 0.98, CH2Cl2). 1H NMR (200 MHz, CDCl3): δ = 3.86 (d, J = 12.7 Hz, 1 H), 3.71 (d, J = 10.7 Hz, 1 H), 3.66 (d, J = 12.7 Hz, 1 H), 3.56 (d, J = 10.7 Hz, 1 H), 2.59 (dd, J = 4.5 Hz, J = 4.5 Hz, 1 H), 2.48-2.25 (m, 2 H), 2.14-1.93 (m, 1 H), 1.98 (d, J = 18.5 Hz, 1 H), 1.61-1.38 (m, 2 H), 1.12 (s, 3 H) ppm. 13C NMR (50 MHz, CDCl3): δ = 214.2, 62.7, 52.2, 42.3, 41.2, 41.1, 39.9, 25.8, 24.8, 16.9 ppm. IR (CCl4): ν = 2964, 1747, 1415, 1385 cm-1. MS: m/z (%) = 185 (3) [M+ - 79], 171 (31), 121 (24), 107 (100), 93 (31), 79 (42), 39 (50). HRMS: calcd for
C10H14BrClO: 263.9916. Found: 263.9915. Compound 1(Br/I): 80% yield. Mp 120-122 °C. [α]D
20 +44.9 (c 0.72, CH2Cl2). 1H NMR (200 MHz, CDCl3): δ = 3.67 (dd, J = 10.5 Hz, J = 1.0 Hz, 1 H), 3.55 (d, J = 10.5 Hz, 1 H), 3.44 (d, J = 11.2 Hz, 1 H), 3.17 (d, J = 11.2 Hz, 1 H), 2.61 (dd, J = 4.4 Hz, J = 4.4 Hz, 1 H), 2.40 (dm, J = 18.5 Hz, 1 H), 2.23-1.91 (m, 2 H), 1.98 (d, J = 18.5 Hz, 1 H), 1.70-1.43 (m, 2 H), 1.07 (s, 3 H) ppm. 13C NMR (50 MHz, CDCl3):
δ = 214.0, 60.8, 52.4, 42.0, 41.5, 39.4, 29.5, 26.1, 16.8, 0.3 ppm. IR (CCl4): ν = 2962, 1745, 1456, 1058 cm-1. MS: m/z (%) = 231 (10) [M+·- 127], 229 (9), 189 (4), 187 (4), 149 (6), 121 (70), 107 (100), 93 (45), 79 (60),
67 (22), 41 (58). HRMS: calcd for C10H14BrIO: 355.9273. Found: 355.9269.